Fatty Acid-Binding Protein 3 is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults

Manuscript Number: 

22-0524R1

Author(s): 
Alexandra L. Clark, Audrey Duarte, Andreanna P. Haley, Sid E. O’Bryant

Disclosures

Alexandra L. Clark

  • Nothing to Disclose

Audrey Duarte

  • Nothing to Disclose

Andreanna P. Haley

  • Nothing to Disclose

Sid E. O’Bryant

  • Equity:
    Dr. O'Bryant owns stock, and is the founding scientist, for Cx Precision Medicine.
    Patents/Royalties
    Dr. O'Bryant holds multiple patents on precision medicine approaches for neurodegenerative diseases.